{"id":52535,"date":"2024-10-11T10:39:59","date_gmt":"2024-10-11T08:39:59","guid":{"rendered":"https:\/\/www.fyb.de\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/"},"modified":"2024-10-16T10:40:44","modified_gmt":"2024-10-16T08:40:44","slug":"mcdermott-advises-subjectwell-on-the-acquisition-of-trials24","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/","title":{"rendered":"McDermott advises SubjectWell on the acquisition of Trials24"},"content":{"rendered":"<p>Chicago\/ Frankfurt\/ Munich \u2014 Subject\u00adWell, a US-based provi\u00adder of digi\u00adtal pati\u00adent recruit\u00adment solu\u00adti\u00adons, has acqui\u00adred Trials24. This stra\u00adte\u00adgic part\u00adner\u00adship will provide pati\u00adents world\u00adwide with access to inno\u00adva\u00adtive forms of treat\u00adment. McDer\u00admott Will &amp; Emery advi\u00adsed Subject\u00adWell compre\u00adhen\u00adsi\u00advely on this tran\u00adsac\u00adtion. Trials24, head\u00adquar\u00adte\u00adred in Munich, acce\u00adle\u00adra\u00adtes pati\u00adent recruit\u00adment for clini\u00adcal trials world\u00adwide and helps CROs and biophar\u00admaceu\u00adti\u00adcal compa\u00adnies to find pati\u00adents who are not within reach of their sites. CROs stands for <i>Clini\u00adcal Rese\u00adarch Orga\u00adniza\u00adtion<\/i>, which takes over tasks in the plan\u00adning and execu\u00adtion of clini\u00adcal trials. Subject\u00adWell is a port\u00adfo\u00adlio company of <strong>Wind\u00adrose Health Inves\u00adtors<\/strong>. Wind\u00adrose invests in compa\u00adnies that specia\u00adlize in services in the health\u00adcare indus\u00adtry and acqui\u00adred Subject\u00adWell in April&nbsp;2024.&nbsp;<\/p>\n<p><strong>Advi\u00adsor Subject\u00adWell: McDer\u00admott Will &amp;&nbsp;Emery<\/strong><\/p>\n<p><strong>Holger Ebers\u00adber\u00adger<\/strong> (Munich), <strong>Dr. Felix Ganzer<\/strong>, photo \u00a9 MWE (Frank\u00adfurt; both lead), Jarrett Szczesny (Chicago; all Private Equity), Jana Grieb (Health\u00adcare), Dr. Chris\u00adtian Rolf (Employ\u00adment), Dr. Florian Schie\u00adfer (Tax; all Frank\u00adfurt), Dr. Claus F\u00e4rber (Coun\u00adsel, IT, Munich); Asso\u00adcia\u00adtes: Dr. Armin Teymouri (Private Equity, Munich), Dr. Lea Hach\u00admeis\u00adter (Health\u00adcare), Constanze G\u00f6tz (Public Law; both Frank\u00adfurt), Janek Joos\u00adten (Employ\u00adment Law, D\u00fcssel\u00addorf) With over 160 lawy\u00aders in 21 offices, McDer\u00admot\u00adt\u2019s Private Equity prac\u00adtice is one of the most active PE law firms world\u00adwide. The prac\u00adtice has been ranked among the top 5 PE firms in health\u00adcare by Pitch\u00adbook for six conse\u00adcu\u00adtive years and is among the top 10 for PE buyouts and other PE deals. Bloom\u00adberg ranks McDer\u00admott among the Top 10 Global Mid-Market PE Firms, while The Deal ranks the firm 7th among PE Law Firms. Further infor\u00adma\u00adtion can be found at pe.mwe.com.<\/p>\n<p><strong>About McDer\u00admott Will &amp;&nbsp;Emery<\/strong><\/p>\n<p>McDer\u00admott Will &amp; Emery is a leading inter\u00adna\u00adtio\u00adnal law firm with more than 1,400 lawy\u00aders in more than 20 offices in Europe, North America and Asia. Our lawy\u00aders cover the entire spec\u00adtrum of commer\u00adcial and corpo\u00adrate law with their advice. The German prac\u00adtice is mana\u00adged by McDer\u00admott Will &amp; Emery Rechts\u00adan\u00adw\u00e4lte Steu\u00ader\u00adbe\u00adra\u00adter LLP. https:\/\/www.mwe.com\/de\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chicago\/ Frankfurt\/ Munich \u2014 Subject\u00adWell, a US-based provi\u00adder of digi\u00adtal pati\u00adent recruit\u00adment solu\u00adti\u00adons, has acqui\u00adred Trials24. This stra\u00adte\u00adgic part\u00adner\u00adship will provide pati\u00adents world\u00adwide with access to inno\u00adva\u00adtive forms of treat\u00adment. McDer\u00admott Will &amp; Emery advi\u00adsed Subject\u00adWell compre\u00adhen\u00adsi\u00advely on this tran\u00adsac\u00adtion. Trials24, head\u00adquar\u00adte\u00adred in Munich, acce\u00adle\u00adra\u00adtes pati\u00adent recruit\u00adment for clini\u00adcal trials world\u00adwide and helps CROs&nbsp;and&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":52533,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369],"tags":[],"class_list":["post-52535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will &amp; Emery advised SubjectWell comprehensively on this transaction.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will &amp; Emery advised SubjectWell comprehensively on this transaction.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-11T08:39:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-16T08:40:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"793\" \/>\n\t<meta property=\"og:image:height\" content=\"481\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"McDermott advises SubjectWell on the acquisition of Trials24\",\"datePublished\":\"2024-10-11T08:39:59+00:00\",\"dateModified\":\"2024-10-16T08:40:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\"},\"wordCount\":329,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\",\"url\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\",\"name\":\"McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg\",\"datePublished\":\"2024-10-11T08:39:59+00:00\",\"dateModified\":\"2024-10-16T08:40:44+00:00\",\"description\":\"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will & Emery advised SubjectWell comprehensively on this transaction.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg\",\"width\":793,\"height\":481,\"caption\":\"Gittings Global - NE112804\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"McDermott advises SubjectWell on the acquisition of Trials24\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook","description":"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will & Emery advised SubjectWell comprehensively on this transaction.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/","og_locale":"en_US","og_type":"article","og_title":"McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook","og_description":"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will & Emery advised SubjectWell comprehensively on this transaction.","og_url":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-10-11T08:39:59+00:00","article_modified_time":"2024-10-16T08:40:44+00:00","og_image":[{"width":793,"height":481,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"McDermott advises SubjectWell on the acquisition of Trials24","datePublished":"2024-10-11T08:39:59+00:00","dateModified":"2024-10-16T08:40:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/"},"wordCount":329,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg","articleSection":["General","Featured","Private equity","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/","url":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/","name":"McDermott advises SubjectWell on the acquisition of Trials24 - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg","datePublished":"2024-10-11T08:39:59+00:00","dateModified":"2024-10-16T08:40:44+00:00","description":"Chicago\/ Frankfurt\/ Munich - SubjectWell, a US-based provider of digital patient recruitment solutions, has acquired Trials24. This strategic partnership will provide patients worldwide with access to innovative forms of treatment. McDermott Will & Emery advised SubjectWell comprehensively on this transaction.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/mwe-ganzer-felix.jpg","width":793,"height":481,"caption":"Gittings Global - NE112804"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/mcdermott-advises-subjectwell-on-the-acquisition-of-trials24\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"McDermott advises SubjectWell on the acquisition of Trials24"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=52535"}],"version-history":[{"count":1,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52535\/revisions"}],"predecessor-version":[{"id":52537,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52535\/revisions\/52537"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/52533"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=52535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=52535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=52535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}